Blood Glucose Monitoring System Market by Product (Self-Monitoring, Continuous Glucose Monitoring Devices), Testing Site (Fingertip), Patient Care Setting (Hospital, Homecare), Application (Type 1, Type 2, Gestational Diabetes) - Global Forecast to 2022
“The blood glucose monitoring system market projected to grow at a CAGR of 4.8%.”
The global blood glucose monitoring system market is projected to reach USD 10.58 billion by 2022 from an estimated USD 8.35 billion in 2017, at a CAGR of 4.8% during the forecast period. The key factors driving the growth of this market include rising prevalence of diabetic population, and increasing product launches. However, the high cost and poor reimbursements is expected to restrain the growth of this market during the forecast period.
By patient care setting, the self/home care segment is expected to grow at the highest CAGR during the forecast period (2017–2022).”
Based on patient care setting, the market is segmented into self/home care and hospitals/clinics. The self/home care segment is expected to account for the largest share of the blood glucose monitoring system market. This can be attributed to high adoption of these devices for home use owing to technological advancements increasing their accuracy and patient comfort.
“By application, the type 1 diabetes segment is expected to grow at the highest CAGR during the forecast period (2017–2022).”
Based on application, the market is segmented into type 1 diabetes, type 2 diabetes, and gestational diabetes.
The type 1 diabetes segment is expected to grow at a highest CAGR owing to increasing product launches of continuous glucose monitors that are used for better management of type 1 diabetes.
“North America to witness the highest growth during the forecast period (2017-2022)”
North America is expected to witness the highest growth during 2017 to 2022. The highest growth rate of the North American market is attributed to rising prevalence of diabetes in the US and Canada, favorable reimbursements, awareness programs and rising FDA approvals in the US.
Break of primary participants was as mentioned below:
Research Coverage:
The report analyzes the blood glucose monitoring system market and aims at estimating the market size and future growth potential of this market based on various segments such as product, testing site, patient care setting, application, and region. The report also includes competitive analysis of the key players in this market along with their company profiles, product and service offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them garner a greater share. Firms purchasing the report could use one or any combination of the below mentioned five strategies.
This report provides insights into the following pointers:
The global blood glucose monitoring system market is projected to reach USD 10.58 billion by 2022 from an estimated USD 8.35 billion in 2017, at a CAGR of 4.8% during the forecast period. The key factors driving the growth of this market include rising prevalence of diabetic population, and increasing product launches. However, the high cost and poor reimbursements is expected to restrain the growth of this market during the forecast period.
By patient care setting, the self/home care segment is expected to grow at the highest CAGR during the forecast period (2017–2022).”
Based on patient care setting, the market is segmented into self/home care and hospitals/clinics. The self/home care segment is expected to account for the largest share of the blood glucose monitoring system market. This can be attributed to high adoption of these devices for home use owing to technological advancements increasing their accuracy and patient comfort.
“By application, the type 1 diabetes segment is expected to grow at the highest CAGR during the forecast period (2017–2022).”
Based on application, the market is segmented into type 1 diabetes, type 2 diabetes, and gestational diabetes.
The type 1 diabetes segment is expected to grow at a highest CAGR owing to increasing product launches of continuous glucose monitors that are used for better management of type 1 diabetes.
“North America to witness the highest growth during the forecast period (2017-2022)”
North America is expected to witness the highest growth during 2017 to 2022. The highest growth rate of the North American market is attributed to rising prevalence of diabetes in the US and Canada, favorable reimbursements, awareness programs and rising FDA approvals in the US.
Break of primary participants was as mentioned below:
- By Company Type – Tier 1–50%, Tier 2–30% and Tier 3–20%
- By Designation – C-level–30%, Director Level–48%, Others–22%
- By Region – North America–48%, Europe–20%, Asia Pacific–25%, Row–7%
Research Coverage:
The report analyzes the blood glucose monitoring system market and aims at estimating the market size and future growth potential of this market based on various segments such as product, testing site, patient care setting, application, and region. The report also includes competitive analysis of the key players in this market along with their company profiles, product and service offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them garner a greater share. Firms purchasing the report could use one or any combination of the below mentioned five strategies.
This report provides insights into the following pointers:
- Market Penetration: Comprehensive information on the product portfolios of the top players in the blood glucose monitoring system market. The report analyzes the market based on product, testing site, patient care setting, application
- Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the blood glucose monitoring system market
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various blood glucose monitoring system across regions
- Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the blood glucose monitoring system market
- Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the blood glucose monitoring system market
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DESIGN
2.2 RESEARCH APPROACH
2.2.1 SECONDARY RESEARCH
2.2.2 PRIMARY RESEARCH
2.3 MARKET SIZE ESTIMATION
2.4 MARKET DATA VALIDATION AND TRIANGULATION
2.5 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS: MARKET OVERVIEW
4.2 GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT
4.3 GEOGRAPHIC ANALYSIS: GLOBAL SELF-MONITORING/ TRADITIONAL BLOOD GLUCOSE SYSTEMS MARKET, BY COMPONENT
4.4 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT
4.5 GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING
4.6 GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION
4.7 GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE
4.8 GEOGRAPHIC SNAPSHOT: GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Growing prevalence of diabetes
5.2.1.2 Increasing number of product launches
5.2.2 RESTRAINT
5.2.2.1 High cost and poor reimbursement of blood glucose monitoring systems and supplies
5.2.3 OPPORTUNITY
5.2.3.1 Pipeline products and ongoing research
5.2.4 CHALLENGE
5.2.4.1 Invasiveness of blood glucose monitors
6 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 SELF-MONITORING BLOOD GLUCOSE SYSTEMS
6.2.1 BLOOD GLUCOSE METERS
6.2.2 TESTING STRIPS
6.2.3 LANCETS & LANCING DEVICES
6.3 CONTINUOUS GLUCOSE MONITORING SYSTEMS
6.3.1 SENSORS
6.3.2 TRANSMITTERS
6.3.3 RECEIVERS
7 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE
7.1 INTRODUCTION
7.2 FINGERTIP TESTING
7.3 ALTERNATE SITE TESTING
8 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING
8.1 INTRODUCTION
8.2 SELF/HOME CARE
8.3 HOSPITALS & CLINICS
9 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION
9.1 INTRODUCTION
9.2 DIABETES
9.2.1 TYPE 2 DIABETES
9.2.1.1 Adults
9.2.1.2 Pediatrics
9.2.2 TYPE 1 DIABETES
9.2.2.1 Adults
9.2.2.2 Pediatrics
9.2.3 GESTATIONAL DIABETES
10 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 US
10.2.2 CANADA
10.3 EUROPE
10.3.1 GERMANY
10.3.2 UK
10.3.3 FRANCE
10.3.4 REST OF EUROPE (ROE)
10.4 ASIA PACIFIC (APAC)
10.4.1 CHINA
10.4.2 INDIA
10.4.3 JAPAN
10.4.4 REST OF APAC
10.5 REST OF THE WORLD (ROW)
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 MARKET SHARE ANALYSIS
11.2.1 SELF-MONITORING/TRADITIONAL BLOOD GLUCOSE SYSTEMS MARKET
11.2.2 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET
11.3 COMPETITIVE SCENARIO
11.3.1 PRODUCT LAUNCHES AND APPROVALS
11.3.2 AGREEMENTS, COLLABORATIONS, CONTRACTS, AND PARTNERSHIPS
11.3.3 EXPANSIONS
11.3.4 ACQUISITIONS
12 COMPANY PROFILES
(Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, Recent Developments)*
12.1 ABBOTT LABORATORIES
12.2 F. HOFFMANN-LA ROCHE
12.3 LIFESCAN
12.4 ASCENSIA DIABETES CARE
12.5 DEXCOM
12.6 MEDTRONIC
12.7 YPSOMED
12.8 B. BRAUN MELSUNGEN
12.9 NIPRO
12.10 SANOFI
12.11 ARKRAY
12.12 PRODIGY DIABETES CARE
12.13 ACON LABORATORIES
12.14 NOVA BIOMEDICAL
*Details on MarketsandMarkets view, Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, and Recent Developments might not be captured in case of unlisted companies.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
13.4 AVAILABLE CUSTOMIZATIONS
13.5 RELATED REPORTS
13.6 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DESIGN
2.2 RESEARCH APPROACH
2.2.1 SECONDARY RESEARCH
2.2.2 PRIMARY RESEARCH
2.3 MARKET SIZE ESTIMATION
2.4 MARKET DATA VALIDATION AND TRIANGULATION
2.5 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS: MARKET OVERVIEW
4.2 GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT
4.3 GEOGRAPHIC ANALYSIS: GLOBAL SELF-MONITORING/ TRADITIONAL BLOOD GLUCOSE SYSTEMS MARKET, BY COMPONENT
4.4 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT
4.5 GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING
4.6 GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION
4.7 GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE
4.8 GEOGRAPHIC SNAPSHOT: GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Growing prevalence of diabetes
5.2.1.2 Increasing number of product launches
5.2.2 RESTRAINT
5.2.2.1 High cost and poor reimbursement of blood glucose monitoring systems and supplies
5.2.3 OPPORTUNITY
5.2.3.1 Pipeline products and ongoing research
5.2.4 CHALLENGE
5.2.4.1 Invasiveness of blood glucose monitors
6 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 SELF-MONITORING BLOOD GLUCOSE SYSTEMS
6.2.1 BLOOD GLUCOSE METERS
6.2.2 TESTING STRIPS
6.2.3 LANCETS & LANCING DEVICES
6.3 CONTINUOUS GLUCOSE MONITORING SYSTEMS
6.3.1 SENSORS
6.3.2 TRANSMITTERS
6.3.3 RECEIVERS
7 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE
7.1 INTRODUCTION
7.2 FINGERTIP TESTING
7.3 ALTERNATE SITE TESTING
8 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING
8.1 INTRODUCTION
8.2 SELF/HOME CARE
8.3 HOSPITALS & CLINICS
9 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION
9.1 INTRODUCTION
9.2 DIABETES
9.2.1 TYPE 2 DIABETES
9.2.1.1 Adults
9.2.1.2 Pediatrics
9.2.2 TYPE 1 DIABETES
9.2.2.1 Adults
9.2.2.2 Pediatrics
9.2.3 GESTATIONAL DIABETES
10 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 US
10.2.2 CANADA
10.3 EUROPE
10.3.1 GERMANY
10.3.2 UK
10.3.3 FRANCE
10.3.4 REST OF EUROPE (ROE)
10.4 ASIA PACIFIC (APAC)
10.4.1 CHINA
10.4.2 INDIA
10.4.3 JAPAN
10.4.4 REST OF APAC
10.5 REST OF THE WORLD (ROW)
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 MARKET SHARE ANALYSIS
11.2.1 SELF-MONITORING/TRADITIONAL BLOOD GLUCOSE SYSTEMS MARKET
11.2.2 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET
11.3 COMPETITIVE SCENARIO
11.3.1 PRODUCT LAUNCHES AND APPROVALS
11.3.2 AGREEMENTS, COLLABORATIONS, CONTRACTS, AND PARTNERSHIPS
11.3.3 EXPANSIONS
11.3.4 ACQUISITIONS
12 COMPANY PROFILES
(Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, Recent Developments)*
12.1 ABBOTT LABORATORIES
12.2 F. HOFFMANN-LA ROCHE
12.3 LIFESCAN
12.4 ASCENSIA DIABETES CARE
12.5 DEXCOM
12.6 MEDTRONIC
12.7 YPSOMED
12.8 B. BRAUN MELSUNGEN
12.9 NIPRO
12.10 SANOFI
12.11 ARKRAY
12.12 PRODIGY DIABETES CARE
12.13 ACON LABORATORIES
12.14 NOVA BIOMEDICAL
*Details on MarketsandMarkets view, Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, and Recent Developments might not be captured in case of unlisted companies.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
13.4 AVAILABLE CUSTOMIZATIONS
13.5 RELATED REPORTS
13.6 AUTHOR DETAILS
LIST OF TABLES
TABLE 1 TOP 10 COUNTRIES WITH THE HIGHEST NUMBER OF DIABETICS (20–79 YEARS), 2017 VS. 2045
TABLE 2 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 3 SELF-MONITORING BLOOD GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE 4 SELF-MONITORING BLOOD GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS)
TABLE 5 BLOOD GLUCOSE METERS MARKET, BY REGION, 2015–2022 (USD MILLION)
TABLE 6 BLOOD GLUCOSE METERS MARKET, BY REGION, 2015–2022 (THOUSAND UNITS)
TABLE 7 TESTING STRIPS MARKET, BY REGION, 2015–2022 (USD MILLION)
TABLE 8 TESTING STRIPS MARKET, BY REGION, 2015–2022 (THOUSAND UNITS)
TABLE 9 LANCING DEVICES MARKET, BY REGION, 2015–2022 (USD MILLION)
TABLE 10 LANCING DEVICES MARKET, BY REGION, 2015–2022 (THOUSAND UNITS)
TABLE 11 LANCETS MARKET, BY REGION, 2015–2022 (USD MILLION)
TABLE 12 LANCETS MARKET, BY REGION, 2015–2022 (THOUSAND UNITS)
TABLE 13 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE 14 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS)
TABLE 15 SENSORS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE 16 SENSORS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS)
TABLE 17 TRANSMITTERS MARKET, BY REGION, 2015–2022 (USD MILLION)
TABLE 18 TRANSMITTERS MARKET, BY REGION, 2015–2022 (THOUSAND UNITS)
TABLE 19 RECEIVERS MARKET, BY REGION, 2015–2022 (USD MILLION)
TABLE 20 RECEIVERS MARKET, BY REGION, 2015–2022 (THOUSAND UNITS)
TABLE 21 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE, 2015–2022 (USD MILLION)
TABLE 22 BLOOD GLUCOSE MONITORING SYSTEMS MARKET FOR FINGERTIP TESTING, BY REGION, 2015–2022 (USD MILLION)
TABLE 23 BLOOD GLUCOSE MONITORING SYSTEMS MARKET FOR ALTERNATE SITE TESTING, BY REGION, 2015–2022 (USD MILLION)
TABLE 24 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING, 2015–2022 (USD MILLION)
TABLE 25 BLOOD GLUCOSE MONITORING SYSTEMS MARKET FOR HOME/SELF CARE, BY REGION, 2015–2022 (USD MILLION)
TABLE 26 BLOOD GLUCOSE MONITORING SYSTEMS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2015–2022 (USD MILLION)
TABLE 27 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 28 BLOOD GLUCOSE MONITORING SYSTEMS MARKET FOR TYPE 2 DIABETES, BY TYPE, 2015–2022 (USD MILLION)
TABLE 29 BLOOD GLUCOSE MONITORING SYSTEMS MARKET FOR TYPE 2 DIABETES, BY REGION, 2015–2022 (USD MILLION)
TABLE 30 BLOOD GLUCOSE MONITORING SYSTEMS MARKET FOR TYPE 2 DIABETES IN ADULTS, BY REGION, 2015–2022 (USD MILLION)
TABLE 31 BLOOD GLUCOSE MONITORING SYSTEMS MARKET FOR TYPE 2 DIABETES IN PEDIATRICS, BY REGION, 2015–2022 (USD MILLION)
TABLE 32 BLOOD GLUCOSE MONITORING SYSTEMS MARKET FOR TYPE 1 DIABETES, BY TYPE, 2015–2022 (USD MILLION)
TABLE 33 BLOOD GLUCOSE MONITORING SYSTEMS MARKET FOR TYPE 1 DIABETES, BY REGION, 2015–2022 (USD MILLION)
TABLE 34 BLOOD GLUCOSE MONITORING SYSTEMS MARKET FOR TYPE 1 DIABETES IN ADULTS, BY REGION, 2015–2022 (USD MILLION)
TABLE 35 BLOOD GLUCOSE MONITORING SYSTEMS MARKET FOR TYPE 1 DIABETES IN PEDIATRICS, BY REGION, 2015–2022 (USD MILLION)
TABLE 36 BLOOD GLUCOSE MONITORING SYSTEMS MARKET FOR GESTATIONAL DIABETES, BY REGION, 2015–2022 (USD MILLION)
TABLE 37 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2015–2022 (USD MILLION)
TABLE 38 NORTH AMERICA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 39 NORTH AMERICA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 40 NORTH AMERICA: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE 41 NORTH AMERICA: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS)
TABLE 42 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE 43 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS)
TABLE 44 NORTH AMERICA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE, 2015–2022 (USD MILLION)
TABLE 45 NORTH AMERICA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING, 2015–2022 (USD MILLION)
TABLE 46 NORTH AMERICA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 47 FDA APPROVALS OF BLOOD GLUCOSE MONITORING SYSTEMS (2014–2017)
TABLE 48 US: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 49 US: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE 50 US: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS)
TABLE 51 US: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE 52 US: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS)
TABLE 53 US: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE, 2015–2022 (USD MILLION)
TABLE 54 US: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING, 2015–2022 (USD MILLION)
TABLE 55 US: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 56 QUANTITY LIMITS FOR BLOOD GLUCOSE TEST STRIPS
TABLE 57 CANADA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 58 CANADA: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE 59 CANADA: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS)
TABLE 60 CANADA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE 61 CANADA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS)
TABLE 62 CANADA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE, 2015–2022 (USD MILLION)
TABLE 63 CANADA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING, 2015–2022 (USD MILLION)
TABLE 64 CANADA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 65 EUROPE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 66 EUROPE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 67 EUROPE: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE 68 EUROPE: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS)
TABLE 69 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE 70 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS)
TABLE 71 EUROPE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE, 2015–2022 (USD MILLION)
TABLE 72 EUROPE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING, 2015–2022 (USD MILLION)
TABLE 73 EUROPE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 74 GERMANY: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 75 GERMANY: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE 76 GERMANY: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS)
TABLE 77 GERMANY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE 78 GERMANY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS)
TABLE 79 GERMANY: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE, 2015–2022 (USD MILLION)
TABLE 80 GERMANY: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING, 2015–2022 (USD MILLION)
TABLE 81 GERMANY: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 82 UK: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 83 UK: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE 84 UK: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS)
TABLE 85 UK: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE 86 UK: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS)
TABLE 87 UK: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE, 2015–2022 (USD MILLION)
TABLE 88 UK: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING, 2015–2022 (USD MILLION)
TABLE 89 UK: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 90 FRANCE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 91 FRANCE: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE 92 FRANCE: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS)
TABLE 93 FRANCE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE 94 FRANCE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS)
TABLE 95 FRANCE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE, 2015–2022 (USD MILLION)
TABLE 96 FRANCE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING, 2015–2022 (USD MILLION)
TABLE 97 FRANCE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 98 ROE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 99 ROE: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE 100 ROE: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS)
TABLE 101 ROE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE 102 ROE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS)
TABLE 103 ROE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE, 2015–2022 (USD MILLION)
TABLE 104 ROE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING, 2015–2022 (USD MILLION)
TABLE 105 ROE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 106 DIABETES PREVALENCE IN APAC, BY COUNTRY
TABLE 107 APAC: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 108 APAC: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 109 APAC: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE 110 APAC: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS)
TABLE 111 APAC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE 112 APAC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS)
TABLE 113 APAC: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE, 2015–2022 (USD MILLION)
TABLE 114 APAC: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING, 2015–2022 (USD MILLION)
TABLE 115 APAC: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 116 CHINA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 117 CHINA: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE 118 CHINA: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS)
TABLE 119 CHINA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE 120 CHINA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS)
TABLE 121 CHINA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE, 2015–2022 (USD MILLION)
TABLE 122 CHINA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING, 2015–2022 (USD MILLION)
TABLE 123 CHINA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 124 INDIA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 125 INDIA: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE 126 INDIA: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS)
TABLE 127 INDIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE 128 INDIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS)
TABLE 129 INDIA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE, 2015–2022 (USD MILLION)
TABLE 130 INDIA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING, 2015–2022 (USD MILLION)
TABLE 131 INDIA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 132 JAPAN: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 133 JAPAN: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE 134 JAPAN: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS)
TABLE 135 JAPAN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE 136 JAPAN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS)
TABLE 137 JAPAN: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE, 2015–2022 (USD MILLION)
TABLE 138 JAPAN: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING, 2015–2022 (USD MILLION)
TABLE 139 JAPAN: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 140 ROAPAC: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 141 ROAPAC: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE 142 ROAPAC: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS)
TABLE 143 ROAPAC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE 144 ROAPAC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS)
TABLE 145 ROAPAC: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE, 2015–2022 (USD MILLION)
TABLE 146 ROAPAC: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING, 2015–2022 (USD MILLION)
TABLE 147 ROAPAC: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 148 CONFERENCE IN AFRICA, BRAZIL, AND THE MIDDLE EAST (2015–2017)
TABLE 149 ROW: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 150 ROW: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE 151 ROW: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS)
TABLE 152 ROW: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE 153 ROW: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS)
TABLE 154 ROW: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE, 2015–2022 (USD MILLION)
TABLE 155 ROW: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING, 2015–2022 (USD MILLION)
TABLE 156 ROW: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 157 PRODUCT LAUNCHES AND APPROVALS (2014-2017)
TABLE 158 AGREEMENTS, COLLABORATIONS, CONTRACTS, AND PARTNERSHIPS
TABLE 159 EXPANSIONS
TABLE 160 ACQUISITIONS
TABLE 1 TOP 10 COUNTRIES WITH THE HIGHEST NUMBER OF DIABETICS (20–79 YEARS), 2017 VS. 2045
TABLE 2 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 3 SELF-MONITORING BLOOD GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE 4 SELF-MONITORING BLOOD GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS)
TABLE 5 BLOOD GLUCOSE METERS MARKET, BY REGION, 2015–2022 (USD MILLION)
TABLE 6 BLOOD GLUCOSE METERS MARKET, BY REGION, 2015–2022 (THOUSAND UNITS)
TABLE 7 TESTING STRIPS MARKET, BY REGION, 2015–2022 (USD MILLION)
TABLE 8 TESTING STRIPS MARKET, BY REGION, 2015–2022 (THOUSAND UNITS)
TABLE 9 LANCING DEVICES MARKET, BY REGION, 2015–2022 (USD MILLION)
TABLE 10 LANCING DEVICES MARKET, BY REGION, 2015–2022 (THOUSAND UNITS)
TABLE 11 LANCETS MARKET, BY REGION, 2015–2022 (USD MILLION)
TABLE 12 LANCETS MARKET, BY REGION, 2015–2022 (THOUSAND UNITS)
TABLE 13 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE 14 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS)
TABLE 15 SENSORS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE 16 SENSORS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS)
TABLE 17 TRANSMITTERS MARKET, BY REGION, 2015–2022 (USD MILLION)
TABLE 18 TRANSMITTERS MARKET, BY REGION, 2015–2022 (THOUSAND UNITS)
TABLE 19 RECEIVERS MARKET, BY REGION, 2015–2022 (USD MILLION)
TABLE 20 RECEIVERS MARKET, BY REGION, 2015–2022 (THOUSAND UNITS)
TABLE 21 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE, 2015–2022 (USD MILLION)
TABLE 22 BLOOD GLUCOSE MONITORING SYSTEMS MARKET FOR FINGERTIP TESTING, BY REGION, 2015–2022 (USD MILLION)
TABLE 23 BLOOD GLUCOSE MONITORING SYSTEMS MARKET FOR ALTERNATE SITE TESTING, BY REGION, 2015–2022 (USD MILLION)
TABLE 24 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING, 2015–2022 (USD MILLION)
TABLE 25 BLOOD GLUCOSE MONITORING SYSTEMS MARKET FOR HOME/SELF CARE, BY REGION, 2015–2022 (USD MILLION)
TABLE 26 BLOOD GLUCOSE MONITORING SYSTEMS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2015–2022 (USD MILLION)
TABLE 27 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 28 BLOOD GLUCOSE MONITORING SYSTEMS MARKET FOR TYPE 2 DIABETES, BY TYPE, 2015–2022 (USD MILLION)
TABLE 29 BLOOD GLUCOSE MONITORING SYSTEMS MARKET FOR TYPE 2 DIABETES, BY REGION, 2015–2022 (USD MILLION)
TABLE 30 BLOOD GLUCOSE MONITORING SYSTEMS MARKET FOR TYPE 2 DIABETES IN ADULTS, BY REGION, 2015–2022 (USD MILLION)
TABLE 31 BLOOD GLUCOSE MONITORING SYSTEMS MARKET FOR TYPE 2 DIABETES IN PEDIATRICS, BY REGION, 2015–2022 (USD MILLION)
TABLE 32 BLOOD GLUCOSE MONITORING SYSTEMS MARKET FOR TYPE 1 DIABETES, BY TYPE, 2015–2022 (USD MILLION)
TABLE 33 BLOOD GLUCOSE MONITORING SYSTEMS MARKET FOR TYPE 1 DIABETES, BY REGION, 2015–2022 (USD MILLION)
TABLE 34 BLOOD GLUCOSE MONITORING SYSTEMS MARKET FOR TYPE 1 DIABETES IN ADULTS, BY REGION, 2015–2022 (USD MILLION)
TABLE 35 BLOOD GLUCOSE MONITORING SYSTEMS MARKET FOR TYPE 1 DIABETES IN PEDIATRICS, BY REGION, 2015–2022 (USD MILLION)
TABLE 36 BLOOD GLUCOSE MONITORING SYSTEMS MARKET FOR GESTATIONAL DIABETES, BY REGION, 2015–2022 (USD MILLION)
TABLE 37 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2015–2022 (USD MILLION)
TABLE 38 NORTH AMERICA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 39 NORTH AMERICA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 40 NORTH AMERICA: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE 41 NORTH AMERICA: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS)
TABLE 42 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE 43 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS)
TABLE 44 NORTH AMERICA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE, 2015–2022 (USD MILLION)
TABLE 45 NORTH AMERICA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING, 2015–2022 (USD MILLION)
TABLE 46 NORTH AMERICA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 47 FDA APPROVALS OF BLOOD GLUCOSE MONITORING SYSTEMS (2014–2017)
TABLE 48 US: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 49 US: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE 50 US: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS)
TABLE 51 US: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE 52 US: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS)
TABLE 53 US: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE, 2015–2022 (USD MILLION)
TABLE 54 US: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING, 2015–2022 (USD MILLION)
TABLE 55 US: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 56 QUANTITY LIMITS FOR BLOOD GLUCOSE TEST STRIPS
TABLE 57 CANADA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 58 CANADA: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE 59 CANADA: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS)
TABLE 60 CANADA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE 61 CANADA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS)
TABLE 62 CANADA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE, 2015–2022 (USD MILLION)
TABLE 63 CANADA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING, 2015–2022 (USD MILLION)
TABLE 64 CANADA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 65 EUROPE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 66 EUROPE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 67 EUROPE: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE 68 EUROPE: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS)
TABLE 69 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE 70 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS)
TABLE 71 EUROPE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE, 2015–2022 (USD MILLION)
TABLE 72 EUROPE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING, 2015–2022 (USD MILLION)
TABLE 73 EUROPE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 74 GERMANY: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 75 GERMANY: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE 76 GERMANY: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS)
TABLE 77 GERMANY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE 78 GERMANY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS)
TABLE 79 GERMANY: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE, 2015–2022 (USD MILLION)
TABLE 80 GERMANY: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING, 2015–2022 (USD MILLION)
TABLE 81 GERMANY: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 82 UK: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 83 UK: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE 84 UK: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS)
TABLE 85 UK: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE 86 UK: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS)
TABLE 87 UK: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE, 2015–2022 (USD MILLION)
TABLE 88 UK: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING, 2015–2022 (USD MILLION)
TABLE 89 UK: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 90 FRANCE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 91 FRANCE: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE 92 FRANCE: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS)
TABLE 93 FRANCE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE 94 FRANCE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS)
TABLE 95 FRANCE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE, 2015–2022 (USD MILLION)
TABLE 96 FRANCE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING, 2015–2022 (USD MILLION)
TABLE 97 FRANCE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 98 ROE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 99 ROE: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE 100 ROE: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS)
TABLE 101 ROE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE 102 ROE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS)
TABLE 103 ROE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE, 2015–2022 (USD MILLION)
TABLE 104 ROE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING, 2015–2022 (USD MILLION)
TABLE 105 ROE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 106 DIABETES PREVALENCE IN APAC, BY COUNTRY
TABLE 107 APAC: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 108 APAC: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 109 APAC: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE 110 APAC: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS)
TABLE 111 APAC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE 112 APAC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS)
TABLE 113 APAC: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE, 2015–2022 (USD MILLION)
TABLE 114 APAC: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING, 2015–2022 (USD MILLION)
TABLE 115 APAC: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 116 CHINA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 117 CHINA: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE 118 CHINA: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS)
TABLE 119 CHINA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE 120 CHINA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS)
TABLE 121 CHINA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE, 2015–2022 (USD MILLION)
TABLE 122 CHINA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING, 2015–2022 (USD MILLION)
TABLE 123 CHINA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 124 INDIA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 125 INDIA: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE 126 INDIA: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS)
TABLE 127 INDIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE 128 INDIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS)
TABLE 129 INDIA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE, 2015–2022 (USD MILLION)
TABLE 130 INDIA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING, 2015–2022 (USD MILLION)
TABLE 131 INDIA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 132 JAPAN: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 133 JAPAN: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE 134 JAPAN: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS)
TABLE 135 JAPAN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE 136 JAPAN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS)
TABLE 137 JAPAN: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE, 2015–2022 (USD MILLION)
TABLE 138 JAPAN: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING, 2015–2022 (USD MILLION)
TABLE 139 JAPAN: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 140 ROAPAC: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 141 ROAPAC: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE 142 ROAPAC: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS)
TABLE 143 ROAPAC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE 144 ROAPAC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS)
TABLE 145 ROAPAC: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE, 2015–2022 (USD MILLION)
TABLE 146 ROAPAC: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING, 2015–2022 (USD MILLION)
TABLE 147 ROAPAC: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 148 CONFERENCE IN AFRICA, BRAZIL, AND THE MIDDLE EAST (2015–2017)
TABLE 149 ROW: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 150 ROW: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE 151 ROW: SELF-MONITORING GLUCOSE SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS)
TABLE 152 ROW: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (USD MILLION)
TABLE 153 ROW: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2015–2022 (THOUSAND UNITS)
TABLE 154 ROW: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE, 2015–2022 (USD MILLION)
TABLE 155 ROW: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING, 2015–2022 (USD MILLION)
TABLE 156 ROW: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 157 PRODUCT LAUNCHES AND APPROVALS (2014-2017)
TABLE 158 AGREEMENTS, COLLABORATIONS, CONTRACTS, AND PARTNERSHIPS
TABLE 159 EXPANSIONS
TABLE 160 ACQUISITIONS
LIST OF FIGURES
FIGURE 1 RESEARCH DESIGN: GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET
FIGURE 2 GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET: RESEARCH METHODOLOGY STEPS
FIGURE 3 SECONDARY SOURCES
FIGURE 4 SAMPLING FRAME: PRIMARY RESEARCH
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 6 PRIMARY SOURCES
FIGURE 7 KEY INDUSTRY INSIGHTS
FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
FIGURE 9 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
FIGURE 10 DATA TRIANGULATION METHODOLOGY
FIGURE 11 SELF-MONITORING BLOOD GLUCOSE SYSTEMS TO DOMINATE THE GLOBAL MARKET IN 2017
FIGURE 12 TESTING STRIPS TO DOMINATE THE SELF-MONITORING/TRADITIONAL BLOOD GLUCOSE SYSTEMS MARKET, BY COMPONENT (2017)
FIGURE 13 SENSORS TO DOMINATE THE GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT (2017)
FIGURE 14 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING (2017)
FIGURE 15 TYPE 2 DIABETES TO DOMINATE THE BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION (2017)
FIGURE 16 FINGERTIP TESTING TO DOMINATE THE BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE IN 2017
FIGURE 17 NORTH AMERICA IS SLATED TO WITNESS THE HIGHEST MARKET GROWTH IN THE BLOOD GLUCOSE MONITORING SYSTEMS MARKET DURING THE FORECAST PERIOD
FIGURE 18 PRODUCT ENHANCEMENTS IN BLOOD GLUCOSE MONITORING SYSTEMS AND GROWING DIABETIC POPULATION ARE DRIVING MARKET GROWTH
FIGURE 19 SELF-MONITORING BLOOD GLUCOSE SYSTEMS TO DOMINATE THE BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT IN 2017
FIGURE 20 TESTING STRIPS TO DOMINATE THE GLOBAL SELF-MONITORING/TRADITIONAL BLOOD GLUCOSE SYSTEMS MARKET IN 2017
FIGURE 21 SENSORS TO DOMINATE THE GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET IN 2017
FIGURE 22 SELF/HOME CARE TO COMMAND THE LARGEST MARKET SHARE IN 2017
FIGURE 23 TYPE 2 DIABETES TO COMMAND THE LARGEST MARKET SHARE IN 2017
FIGURE 24 FINGERTIP TESTING TO COMMAND THE LARGEST MARKET SHARE IN 2017
FIGURE 25 NORTH AMERICA TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
FIGURE 26 CONTINUOUS GLUCOSE MONITORING SYSTEMS TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
FIGURE 27 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE, 2017 VS. 2022 (USD MILLION)
FIGURE 28 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING
FIGURE 29 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2017 VS. 2022 (USD MILLION)
FIGURE 30 NORTH AMERICA TO COMMAND THE LARGEST MARKET SHARE IN 2017
FIGURE 31 NORTH AMERICA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET SNAPSHOT
FIGURE 32 EUROPE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET SNAPSHOT
FIGURE 33 DIABETES UK: FUNDS RAISED VS. FUNDS INVESTED
FIGURE 34 ASIA-PACIFIC: BLOOD GLUCOSE MONITORING SYSTEMS MARKET SNAPSHOT
FIGURE 35 ROW: BLOOD GLUCOSE MONITORING SYSTEMS MARKET SNAPSHOT
FIGURE 36 SELF-MONITORING/TRADITIONAL BLOOD GLUCOSE SYSTEMS MARKET SHARE, BY KEY PLAYER, 2016
FIGURE 37 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE, BY KEY PLAYER, 2016
FIGURE 38 STRATEGIES ADOPTED BY MARKET PLAYERS (2014–2017)
FIGURE 39 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2016)
FIGURE 40 F. HOFFMANN-LA ROCHE: COMPANY SNAPSHOT (2016)
FIGURE 41 DEXCOM: COMPANY SNAPSHOT (2016)
FIGURE 42 MEDTRONIC: COMPANY SNAPSHOT (2016)
FIGURE 43 YPSOMED: COMPANY SNAPSHOT (2016)
FIGURE 44 B. BRAUN MELSUNGEN: COMPANY SNAPSHOT (2016)
FIGURE 45 NIPRO: COMPANY SNAPSHOT (2016)
FIGURE 46 SANOFI: COMPANY SNAPSHOT (2016)
FIGURE 1 RESEARCH DESIGN: GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET
FIGURE 2 GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET: RESEARCH METHODOLOGY STEPS
FIGURE 3 SECONDARY SOURCES
FIGURE 4 SAMPLING FRAME: PRIMARY RESEARCH
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 6 PRIMARY SOURCES
FIGURE 7 KEY INDUSTRY INSIGHTS
FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
FIGURE 9 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
FIGURE 10 DATA TRIANGULATION METHODOLOGY
FIGURE 11 SELF-MONITORING BLOOD GLUCOSE SYSTEMS TO DOMINATE THE GLOBAL MARKET IN 2017
FIGURE 12 TESTING STRIPS TO DOMINATE THE SELF-MONITORING/TRADITIONAL BLOOD GLUCOSE SYSTEMS MARKET, BY COMPONENT (2017)
FIGURE 13 SENSORS TO DOMINATE THE GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT (2017)
FIGURE 14 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING (2017)
FIGURE 15 TYPE 2 DIABETES TO DOMINATE THE BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION (2017)
FIGURE 16 FINGERTIP TESTING TO DOMINATE THE BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE IN 2017
FIGURE 17 NORTH AMERICA IS SLATED TO WITNESS THE HIGHEST MARKET GROWTH IN THE BLOOD GLUCOSE MONITORING SYSTEMS MARKET DURING THE FORECAST PERIOD
FIGURE 18 PRODUCT ENHANCEMENTS IN BLOOD GLUCOSE MONITORING SYSTEMS AND GROWING DIABETIC POPULATION ARE DRIVING MARKET GROWTH
FIGURE 19 SELF-MONITORING BLOOD GLUCOSE SYSTEMS TO DOMINATE THE BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT IN 2017
FIGURE 20 TESTING STRIPS TO DOMINATE THE GLOBAL SELF-MONITORING/TRADITIONAL BLOOD GLUCOSE SYSTEMS MARKET IN 2017
FIGURE 21 SENSORS TO DOMINATE THE GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET IN 2017
FIGURE 22 SELF/HOME CARE TO COMMAND THE LARGEST MARKET SHARE IN 2017
FIGURE 23 TYPE 2 DIABETES TO COMMAND THE LARGEST MARKET SHARE IN 2017
FIGURE 24 FINGERTIP TESTING TO COMMAND THE LARGEST MARKET SHARE IN 2017
FIGURE 25 NORTH AMERICA TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
FIGURE 26 CONTINUOUS GLUCOSE MONITORING SYSTEMS TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
FIGURE 27 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TESTING SITE, 2017 VS. 2022 (USD MILLION)
FIGURE 28 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY PATIENT CARE SETTING
FIGURE 29 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2017 VS. 2022 (USD MILLION)
FIGURE 30 NORTH AMERICA TO COMMAND THE LARGEST MARKET SHARE IN 2017
FIGURE 31 NORTH AMERICA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET SNAPSHOT
FIGURE 32 EUROPE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET SNAPSHOT
FIGURE 33 DIABETES UK: FUNDS RAISED VS. FUNDS INVESTED
FIGURE 34 ASIA-PACIFIC: BLOOD GLUCOSE MONITORING SYSTEMS MARKET SNAPSHOT
FIGURE 35 ROW: BLOOD GLUCOSE MONITORING SYSTEMS MARKET SNAPSHOT
FIGURE 36 SELF-MONITORING/TRADITIONAL BLOOD GLUCOSE SYSTEMS MARKET SHARE, BY KEY PLAYER, 2016
FIGURE 37 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE, BY KEY PLAYER, 2016
FIGURE 38 STRATEGIES ADOPTED BY MARKET PLAYERS (2014–2017)
FIGURE 39 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2016)
FIGURE 40 F. HOFFMANN-LA ROCHE: COMPANY SNAPSHOT (2016)
FIGURE 41 DEXCOM: COMPANY SNAPSHOT (2016)
FIGURE 42 MEDTRONIC: COMPANY SNAPSHOT (2016)
FIGURE 43 YPSOMED: COMPANY SNAPSHOT (2016)
FIGURE 44 B. BRAUN MELSUNGEN: COMPANY SNAPSHOT (2016)
FIGURE 45 NIPRO: COMPANY SNAPSHOT (2016)
FIGURE 46 SANOFI: COMPANY SNAPSHOT (2016)
